-
Study aim
-
Determining the effect of dexamethasone use in the middle ear during stapedotomy surgery on the hearing results of patients with otosclerosis
-
Design
-
Non-probabilistic and available methods will be used for sampling and random blocking method will be used to assign individuals in the intervention and control groups. In this way, the blocks will be arranged using a table of random numbers, and a code will be assigned to each client and candidate for action, based on which the code will determine whether the person is in the intervention or control group.
-
Settings and conduct
-
In the control group, routine stapedotomy will be performed, and in the intervention group, immediately after perforation of the footplate by the perforator, 0.3 cc of dexamethasone will be placed in the middle ear and on the oval window, and a Teflon piston or titanium prosthesis will be placed inside the oval window. Double-blind (researcher and patient)
-
Participants/Inclusion and exclusion criteria
-
all patients with otosclerosis who have conductive hearing impairment of more than 30 decibels in the recent audiometry in the affected ear.
Patients who have a history of previous stapedotomy surgery or a history of other ear diseases, such as meningitis or upper semicircular canal dehiscence, will be excluded if they do not return within the specified time after surgery.
-
Intervention groups
-
In the control group, routine stapedotomy will be performed, and in the intervention group, immediately after perforation of the footplate by the perforator, 0.3 cc of dexamethasone will be placed in the middle ear and on the oval window, and a Teflon piston or titanium prosthesis will be placed inside the oval window.
-
Main outcome variables
-
Before and 6 months after high frequency full frequency audiometry